Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9569 - 9576 of 11618 results
The Seventh Circuit Rejects Medicaid False Claims Act Suit
November 19, 2014| Blog| Viewpoint
The 340B Mega-Reg is Dead
November 19, 2014| Blog| Viewpoint
Tax Court Characterizes Technology Executive’s Merger Proceeds as Ordinary Income
November 18, 2014| Alert| Viewpoint
ML Strategies Energy and Environment Update: Week of 11/17/2014
November 18, 2014| Blog| Viewpoint
Recent Changes in US Immigration Processes and Technology
November 18, 2014| Advisory| Viewpoint
The Massachusetts Health Insurance Mandate: Some Good News for Massachusetts Taxpayers
November 17, 2014| Blog| Viewpoint
Corrective Action Earns Verizon End to FTC's FiOS Router Investigation
November 14, 2014| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.